Serina Therapeutics (SER) Total Current Liabilities (2018 - 2026)
Serina Therapeutics (SER) posted Total Current Liabilities of $3.6 million for Q4 2025, down 59.46% sequentially from $8.8 million in Q3 2025, and up 50.59% YoY from $2.4 million in Q4 2024.
Serina Therapeutics (SER) Total Current Liabilities (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported Total Current Liabilities for 8 years, with the latest figure at $3.6 million in Q4 2025.
- Quarterly Total Current Liabilities rose 50.59% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (up 50.59% YoY) and the FY2025 annual result came in at $3.6 million, up 50.59% from the prior year.
- Total Current Liabilities eased to $3.6 million in Q4 2025 per SER's latest filing, from $8.8 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $24.5 million in Q2 2023 and troughed at $1.4 million in Q4 2023.
- A 5-year average of $8.8 million and a median of $8.8 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities sank 85.98% in 2023, then soared 321.79% in 2024.
- Over 5 years, Total Current Liabilities stood at $9.0 million in 2021, then gained by 12.39% to $10.1 million in 2022, then tumbled by 85.98% to $1.4 million in 2023, then jumped by 67.45% to $2.4 million in 2024, then surged by 50.59% to $3.6 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $3.6 million, $8.8 million, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 630.93 Mn |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | 3.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.76 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 8.79 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 2.37 Mn |
| Sep 30, 2024 | 13.51 Mn |
| Jun 30, 2024 | 12.63 Mn |
| Mar 31, 2024 | 14.06 Mn |
| Dec 31, 2023 | 1.41 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 24.51 Mn |
| Mar 31, 2023 | 22.53 Mn |
| Dec 31, 2022 | 10.08 Mn |
| Sep 30, 2022 | 8.81 Mn |
| Jun 30, 2022 | 9.09 Mn |
| Mar 31, 2022 | 10.10 Mn |
| Dec 31, 2021 | 8.97 Mn |
| Sep 30, 2021 | 6.60 Mn |
| Jun 30, 2021 | 5.27 Mn |